Parameter
| Biomarker | C4BPA | Full name | Complement component 4 binding protein alpha | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Pancreatic Cancer | ||
| Disease | Pancreas | Disease Subtypes | / | ||
| Organ | Test Sample / Technology Platform | Serum, immunoassay (tandem mass spectrometry (ms)) | |||
| Pathobiological Mechanisms | As a classic way to complement to adjust composition, is produced by liver cells and activation of mononuclear cells, in the early PDAC expression change, can distinguish between PDAC and other gastrointestinal tumors | ||||
| Clinical Availability Status | Clinical research phase: was validated through quantitative proteomics, show the potential for early diagnosis | ||||
| Notes and Dynamics | Is a new type of serum biomarkers for early detection PDAC has specificity, diagnostic panel is expected to be incorporated into joint | ||||